VIRAZOLE PWS 6GM/VIAL DIN 00704008
Health Canada record
| Active ingredient(s) | RIBAVIRIN 6 G |
|---|---|
| Dosage form | Powder For Solution; Aerosol |
| Route | Inhalation |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J05AP01 RIBAVIRIN |
| Original market date | 31-Dec-1986 |
| Current status date | 08-Aug-1997 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing RIBAVIRIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02170140 | VIRAZOLE | BAUSCH HEALTH, CANADA INC. | Powder For Solution; Aerosol | RIBAVIRIN 6 G | Marketed |
| 02439212 | IBAVYR | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Tablet | RIBAVIRIN 200 MG | Dormant |
| 02425890 | IBAVYR | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Tablet | RIBAVIRIN 400 MG | Dormant |
| 02425904 | IBAVYR | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Tablet | RIBAVIRIN 600 MG | Dormant |
| 02436396 | MODERIBA | ABBVIE CORPORATION | Tablet | RIBAVIRIN 200 MG | Cancelled Post Market |
| 02436418 | MODERIBA | ABBVIE CORPORATION | Tablet | RIBAVIRIN 400 MG | Cancelled Post Market |
| 02436426 | MODERIBA | ABBVIE CORPORATION | Tablet | RIBAVIRIN 600 MG | Cancelled Post Market |
| 02254638 | PEGETRON | MERCK CANADA INC | Capsule; Powder For Solution | RIBAVIRIN 200 MG; PEGINTERFERON ALFA-2B 120 MCG | Cancelled Post Market |
| 02254646 | PEGETRON | MERCK CANADA INC | Powder For Solution; Capsule | RIBAVIRIN 200 MG; PEGINTERFERON ALFA-2B 150 MCG | Cancelled Post Market |
| 02246030 | PEGETRON | MERCK CANADA INC | Powder For Solution; Capsule | RIBAVIRIN 200 MG; PEGINTERFERON ALFA-2B 150 MCG | Cancelled Post Market |
| 02246026 | PEGETRON | MERCK CANADA INC | Powder For Solution; Capsule | RIBAVIRIN 200 MG; PEGINTERFERON ALFA-2B 50 MCG | Cancelled Post Market |
| 02246027 | PEGETRON | MERCK CANADA INC | Capsule; Powder For Solution | RIBAVIRIN 200 MG; PEGINTERFERON ALFA-2B 80 MCG | Cancelled Post Market |
| 02246028 | PEGETRON | MERCK CANADA INC | Powder For Solution; Capsule | RIBAVIRIN 200 MG; PEGINTERFERON ALFA-2B 100 MCG | Cancelled Post Market |
| 02246029 | PEGETRON | MERCK CANADA INC | Capsule; Powder For Solution | RIBAVIRIN 200 MG; PEGINTERFERON ALFA-2B 120 MCG | Cancelled Post Market |
| 02254581 | PEGETRON | MERCK CANADA INC | Capsule; Powder For Solution | RIBAVIRIN 200 MG; PEGINTERFERON ALFA-2B 80 MCG | Cancelled Post Market |
| 02254603 | PEGETRON | MERCK CANADA INC | Powder For Solution; Capsule | RIBAVIRIN 200 MG; PEGINTERFERON ALFA-2B 100 MCG | Cancelled Post Market |
| 02239730 | REBETRON READY TO USE SOLUTION (ALBUMIN(HUMAN)FREE) (6000000 IU/ML AND 200MG CAPSULES) | SCHERING-PLOUGH CANADA INC | Kit; Capsule; Liquid | RIBAVIRIN 200 MG; INTERFERON ALFA-2B 6000000 UNIT | Cancelled Post Market |
| 02241159 | REBETRON SOLUTION (ALBUMIN (HUMAN) FREE) (18 MIU MULTI-DOSE PEN / 200MG CAPSULES) | SCHERING-PLOUGH CANADA INC | Liquid; Capsule; Kit | RIBAVIRIN 200 MG; INTERFERON ALFA-2B 15000000 UNIT | Cancelled Post Market |
International API supply for RIBAVIRIN
3 valid EDQM Certificates of Suitability from 3 holders. 5 active FDA Drug Master Files.
Request a quote for VIRAZOLE PWS 6GM/VIAL